These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

638 related items for PubMed ID: 17678713

  • 21. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
    Devreese KMJ, Linskens EA, Benoit D, Peperstraete H.
    J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
    [Abstract] [Full Text] [Related]

  • 22. Coexistence of anti-β2-glycoprotein I domain I and anti-phosphatidylserine/prothrombin antibodies suggests strong thrombotic risk.
    Lee JS, Gu J, Park HS, Yoo HJ, Kim HK.
    Clin Chem Lab Med; 2017 May 01; 55(6):882-889. PubMed ID: 28002027
    [Abstract] [Full Text] [Related]

  • 23. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Khamashta MA, Amengual O, Hughes GR.
    J Rheumatol; 1998 Jun 01; 25(6):1104-8. PubMed ID: 9632071
    [Abstract] [Full Text] [Related]

  • 24. Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant.
    Bertolaccini ML, Sciascia S, Murru V, Garcia-Fernandez C, Sanna G, Khamashta MA.
    Thromb Haemost; 2013 Feb 01; 109(2):207-13. PubMed ID: 23254928
    [Abstract] [Full Text] [Related]

  • 25. Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS?
    Žigon P, Čučnik S, Ambrožič A, Sodin Šemrl S, Kveder T, Božič B.
    Lupus; 2012 Jun 01; 21(7):790-2. PubMed ID: 22635235
    [Abstract] [Full Text] [Related]

  • 26. Detecting anti-prothrombin antibodies in young women with acute ischemic stroke.
    Cojocaru IM, Cojocaru M, Tănăsescu R, Burcin C, Mitu AC, Iliescu I, Dumitrescu L, Pavel I, Silosi I.
    Rom J Intern Med; 2008 Jun 01; 46(4):337-41. PubMed ID: 19480300
    [Abstract] [Full Text] [Related]

  • 27. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME, Cabiedes J, Reyes E, Cabral AR.
    Rev Invest Clin; 2005 Jun 01; 57(4):563-71. PubMed ID: 16315641
    [Abstract] [Full Text] [Related]

  • 28. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J, De Clerck LS, Stevens WJ, Bridts CH, van Cotthem KA, Musial J, Jankowski M, Szczeklik A.
    J Rheumatol; 1997 Sep 01; 24(9):1710-5. PubMed ID: 9292792
    [Abstract] [Full Text] [Related]

  • 29. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, Su Y, Li ZG.
    Clin Rheumatol; 2017 Feb 01; 36(2):401-406. PubMed ID: 28050648
    [Abstract] [Full Text] [Related]

  • 30. Relationship of anti beta2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies.
    Forastiero RR, Martinuzzo ME, Cerrato GS, Kordich LC, Carreras LO.
    Thromb Haemost; 1997 Sep 01; 78(3):1008-14. PubMed ID: 9308745
    [Abstract] [Full Text] [Related]

  • 31. First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β2 -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies Tests.
    Nakamura H, Oku K, Amengual O, Ohmura K, Fujieda Y, Kato M, Bohgaki T, Yasuda S, Atsumi T.
    Arthritis Care Res (Hoboken); 2018 Apr 01; 70(4):627-634. PubMed ID: 28686816
    [Abstract] [Full Text] [Related]

  • 32. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr 01; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 33. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
    Forastiero R.
    Lupus; 2014 Oct 01; 23(12):1252-4. PubMed ID: 25228718
    [Abstract] [Full Text] [Related]

  • 34. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
    Cucnik S, Kveder T, Ulcova-Gallova Z, Swadzba J, Musial J, Valesini G, Avcin T, Rozman B, Bozic B.
    Lupus; 2011 Oct 01; 20(11):1166-71. PubMed ID: 21712304
    [Abstract] [Full Text] [Related]

  • 35. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr 01; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 36. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P, Lehtonen KV, Javela K, Puurunen M.
    Lupus; 2014 Dec 01; 23(14):1468-76. PubMed ID: 25164304
    [Abstract] [Full Text] [Related]

  • 37. IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers.
    Tonello M, Mattia E, Favaro M, Del Ross T, Calligaro A, Salvan E, Hoxha A, Fedrigo M, Ruffatti A.
    Thromb Res; 2019 May 01; 177():157-160. PubMed ID: 30903876
    [Abstract] [Full Text] [Related]

  • 38. Antiprothrombin antibody testing: detection and clinical utility.
    Oku K, Atsumi T, Amengual O, Koike T.
    Semin Thromb Hemost; 2008 Jun 01; 34(4):335-9. PubMed ID: 18814066
    [Abstract] [Full Text] [Related]

  • 39. Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study.
    Sciascia S, Radin M, Cecchi I, Rubini E, Scotta A, Rolla R, Montaruli B, Pergolini P, Mengozzi G, Muccini E, Baldovino S, Ferro M, Vaccarino A, Mahler M, Menegatti E, Roccatello D.
    Front Immunol; 2019 Jun 01; 10():376. PubMed ID: 30891041
    [Abstract] [Full Text] [Related]

  • 40. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
    Horbach DA, van Oort E, Donders RC, Derksen RH, de Groot PG.
    Thromb Haemost; 1996 Dec 01; 76(6):916-24. PubMed ID: 8972011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.